ClinicalTrials.gov
public full text
Public Domain
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer#804844
- A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer#1161409
- Immunologic Signatures Following Surgery for Pancreatic Cancer#813893
- Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma#1163696
- Irreversible Electroporation Ablation for Colorectal Metastases to the Lung#1033519
Record · ID 125837
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive